BioCentury | Jun 20, 2011
Finance

Analyst tracks

...in equity research covering biotechnology and specialty pharmaceuticals companies. He was a managing director with Hapoalim Securities. ...
BioCentury | Apr 19, 2010
Analyst Picks & Changes

Analyst picks & changes

...raised $64.4M in an IPO and concurrent private placement last month. Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Hapoalim Securities...
Items per page:
1 - 2 of 2
BioCentury | Jun 20, 2011
Finance

Analyst tracks

...in equity research covering biotechnology and specialty pharmaceuticals companies. He was a managing director with Hapoalim Securities. ...
BioCentury | Apr 19, 2010
Analyst Picks & Changes

Analyst picks & changes

...raised $64.4M in an IPO and concurrent private placement last month. Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Hapoalim Securities...
Items per page:
1 - 2 of 2